Skip to main content

LH

Stock
Health Care
Diagnostics & Research

Performance overview

LH Price
Price Chart

Forward-looking statistics

Beta
0.36
Risk
20.18%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Company info

SectorHealth Care
IndustryDiagnostics & Research
Employees46K
Market cap$16.6B

Fundamentals

Enterprise value$28.2B
Revenue$13.2B
Revenue per employee—
Profit margin5.55%
Debt to equity79.13

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$8.67
Dividend per share$2.88
Revenue per share$157.30
Avg trading volume (30 day)$169M
Avg trading volume (10 day)$186M
Put-call ratio—

Macro factor sensitivity

Growth+1.5
Credit+2.3
Liquidity-0.9
Inflation-0.3
Commodities+0.4
Interest Rates-1.7

Valuation

Dividend yield1.10%
PEG Ratio16.35
Price to sales1.66
P/E Ratio16.35
Enterprise Value to Revenue2.14
Price to book2.64

Upcoming events

Next earnings dayApril 29, 2025
Next dividend day—
Ex. dividend dayMay 29, 2025

News

Here's Why L3Harris Stock Looks Promising for Your Portfolio Now

LHX's global defense reach, acquisitions and rising earnings outlook make it a strong pick in the aerospace defense industry.

Zacks Investment Research (July 11, 2025)
Buy 3 High-Flying Drone Technology Stocks to Enhance Your Returns

JBL, HEI, and LHX have each surged over 17% in three months, fueled by strong drone tech momentum and rising defense demand.

Zacks Investment Research (July 11, 2025)
Will Celsius' Innovation Strategy Fuel its Next Wave of Growth?

CELH bets big on innovation with new brands, hydration products and retail gains to reignite growth after a soft first quarter.

Zacks Investment Research (July 10, 2025)
Norwegian Cruise Line Holdings Ltd. (NCLH) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Norwegian Cruise Line (NCLH). This makes it worthwhile to examine what the stock has in store.

Zacks Investment Research (July 10, 2025)
Alignment Healthcare (ALHC) Upgraded to Buy: Here's What You Should Know

Alignment Healthcare (ALHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research (July 8, 2025)
What Makes Labcorp (LH) a New Buy Stock

Labcorp (LH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research (July 7, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free